 Myovant Sciences turned down a takeover bid from majority shareholder Sumitovant Biopharma on Monday, and MYOV stock skyrocketed. The post Myovant Sciences Rockets After Rejecting Lowball Sumitovant Biopharma Takeover Bid appeared first on Investors Business Daily. 